Mangoceuticals Inc.

NASDAQ: MGRX · Real-Time Price · USD
1.61
-0.05 (-3.01%)
At close: May 01, 2025, 3:39 PM
-3.01%
Bid 1.61
Market Cap 10.09M
Revenue (ttm) 615.87K
Net Income (ttm) -8.71M
EPS (ttm) -4.84
PE Ratio (ttm) -0.33
Forward PE n/a
Analyst n/a
Ask 1.64
Volume 79,249
Avg. Volume (20D) 281,632
Open 1.66
Previous Close 1.66
Day's Range 1.60 - 1.69
52-Week Range 1.49 - 16.80
Beta 2.42

About MGRX

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc....

Sector Healthcare
IPO Date Mar 21, 2023
Employees 3
Stock Exchange NASDAQ
Ticker Symbol MGRX
Full Company Profile
6 days ago
-13.81%
MGRX stock has given up its prior gain. Mangoceuti... Unlock content with Pro Subscription
6 days ago
-13.81%
Mangoceuticals shares are trading higher after the company entered an Intellectual Property Purchase Agreement for IP and assets of Smokeless Technology Corp.